- Home
- NRT vs VNRX Comparison
NRT vs VNRX Comparison
Compare NRT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- VNRX
- Stock Information
- Founded
- NRT 1975
- VNRX N/A
- Country
- NRT United States
- VNRX United States
- Employees
- NRT N/A
- VNRX N/A
- Industry
- NRT Oil & Gas Production
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NRT Energy
- VNRX Health Care
- Exchange
- NRT Nasdaq
- VNRX Nasdaq
- Market Cap
- NRT 50.9M
- VNRX 40.8M
- IPO Year
- NRT N/A
- VNRX N/A
- Fundamental
- Price
- NRT $6.19
- VNRX $0.32
- Analyst Decision
- NRT
- VNRX Strong Buy
- Analyst Count
- NRT 0
- VNRX 3
- Target Price
- NRT N/A
- VNRX $3.17
- AVG Volume (30 Days)
- NRT 87.9K
- VNRX 2.4M
- Earning Date
- NRT 12-30-2025
- VNRX 11-13-2025
- Dividend Yield
- NRT 13.80%
- VNRX N/A
- EPS Growth
- NRT 24.05
- VNRX N/A
- EPS
- NRT 0.59
- VNRX N/A
- Revenue
- NRT $6,184,173.00
- VNRX $1,472,007.00
- Revenue This Year
- NRT N/A
- VNRX $324.32
- Revenue Next Year
- NRT N/A
- VNRX $247.82
- P/E Ratio
- NRT $10.01
- VNRX N/A
- Revenue Growth
- NRT 18.55
- VNRX 14.48
- 52 Week Low
- NRT $3.88
- VNRX $0.29
- 52 Week High
- NRT $6.95
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- NRT 53.16
- VNRX 34.46
- Support Level
- NRT $5.52
- VNRX $0.29
- Resistance Level
- NRT $6.15
- VNRX $0.35
- Average True Range (ATR)
- NRT 0.32
- VNRX 0.03
- MACD
- NRT -0.06
- VNRX 0.00
- Stochastic Oscillator
- NRT 39.16
- VNRX 22.37
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.